Published in the Journal of Neurodevelopmental Disorders, this peer-reviewed study presents the largest and most detailed analysis to date of FOXG1 syndrome. The results come from the FOXG1 Citizen Health Natural History Study, led by the FOXG1 Research Foundation’s Chief Clinical Data Officer Elli Brimble, in collaboration with Citizen Health and international key clinical partners.

New FOXG1 Research publication in Nature Communications. Title: The patient-specific mouse model withFoxg1frameshift mutation provides insights intothe pathophysiology of FOXG1 syndrome

Groundbreaking Study Shows Promise in AAV9 Gene Therapy for FOXG1 Syndrome; Rescue of Brain Structure Abnormalities and Deficits.

[Buffalo, New York June 10, 2024] – A landmark study led by Dr. Soo-Kyung Lee, Chief Scientific Officer at the FOXG1 Research Foundation and Empire Innovation Professor and Om P. Bahl Endowed Professor in the Department of Biological Sciences at University at Buffalo, and Dr. Jae Lee, Professor in the Department of Biological Sciences at University at Buffalo, in collaboration with Dr. Kathrin Meyer (responsible for the SMA gene therapy), has been published in Molecular Therapy Methods & Clinical Development.